Evidence map›Paper›PMID 27512288›Full record

ArticleJournal of physical therapy science2016

The association of vitamin D with inflammatory cytokines in diabetic peripheral neuropathy.

Bulent Bilir, Feti Tulubas, Betul Ekiz Bilir, Neslihan Soysal Atile, Sonat Pinar Kara, Tulay Yildirim, Seyit Ali Gumustas, Birol Topcu, Ozlem Kaymaz, Murat Aydin

Open access · diamondAbstract read
In one paragraph

Article in Journal of physical therapy science, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Bulent BilirDepartment of Internal Medicine, Namik Kemal University School of Medicine, Turkey.
Feti TulubasDepartment of Biochemistry, Namik Kemal University School of Medicine, Turkey.
Betul Ekiz BilirClinic of Endocrinology, Republic of Turkey Ministry of Health, State Hospital, Turkey.
Neslihan Soysal AtileClinic of Endocrinology, Republic of Turkey Ministry of Health, State Hospital, Turkey.
Sonat Pinar KaraDepartment of Internal Medicine, Namik Kemal University School of Medicine, Turkey.
Tulay YildirimDepartment of Physical Medicine and Rehabilitation, Namik Kemal University School of Medicine, Turkey.
Seyit Ali GumustasDepartment of Orthopaedic and Traumatology, Republic of Turkey Ministry of Health General Secretariat of the Public Hospitals Union, Turkey.
Birol TopcuDepartment of Biostatistics Tekirdag, Namik Kemal University School of Medicine, Turkey.
Ozlem KaymazDepartment of Biochemistry, Namik Kemal University School of Medicine, Turkey.
Murat AydinDepartment of Biochemistry, Namik Kemal University School of Medicine, Turkey.
Namık Kemal University · TRMinistry of Health · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[Purpose] The effects of vitamin D on the circulating levels of IL-17 and IL-13 were investigated in patients with diabetic peripheral neuropathy, patients with diabetes mellitus type 2 without neuropathy, and healthy controls. [Subjects and Methods] A single-blind controlled clinical study was performed, including70 type 2 diabetic patients with or without diabetic peripheral neuropathy and 33 healthy volunteer controls. The 25(OH)D levels were evaluated using ultra-performance liquid chromatography, and IL-17 and IL-13 levels were assessed using enzyme-linked immunosorbent assays. [Results] The 25(OH) vitamin D concentration was lower in diabetic peripheral neuropathy patients than in diabetes mellitus patients without neuropathy and healthy controls. Similarly, 25(OH)D levels were lower in diabetes mellitus patients than healthy controls. IL-17 and IL-13 levels were higher in diabetes mellitus patients than in controls. Additionally, IL-13 levels were higher in diabetic peripheral neuropathy patients than in diabetes mellitus patients without neuropathy. These differences were statistically significant. There was a significant positive correlation between 25(OH)D and IL-13,and a negative correlation between 25(OH)D andIL-17 in the diabetic and diabetic neuropathy groups. [Conclusion] Vitamin D is a potential modifiable risk factor for diabetic peripheral neuropathy and may regulate inflammatory mediators, e.g., IL-17 and IL-13.

Indexed as

CytokinesDiabetic peripheral neuropathyVitamin D

Identifiers

PMID27512288
PMCPMC4968528
OpenAlexW2480304956

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.